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Insulin-like growth factor-1 promoter polymorphisms and
colorectal cancer: a functional genomics approach
Abstract
RATIONALE: Insulin-like growth factor-1 (IGF1) has been proposed to mediate the obesity-related
carcinogenic effects of "Western lifestyle". While genetic factors explain at least half of inter-individual
IGF1 variation, the IGF1 polymorphisms hypothesised to underlie the variation in cancer incidence rates
remain ill-defined. METHODS: We used a comparative genomics approach to identify putative
regulatory polymorphisms in the IGF1 promoter region within a rapidly westernising population, the
Singapore Chinese. Association of IGF1 genotype with colorectal cancer risk was assessed among 298
colorectal cancer cases and 1142 controls nested within the Singapore Chinese Health Study.
RESULTS: We identified a common (minor allele frequency = 0.36) single-nucleotide polymorphism
(SNP), IGF1-2995 C/A, within a consensus domain for an octamer binding factor (Oct1/Oct2)
transcription factor binding site. Possession of one or two copies of the minor allele (genotypes AA and
CA) conferred an approximate 40% decrease in risk in comparison to genotype CC (odds ratio, 0.59;
95% confidence interval, 0.45 to 0.77). This association was stronger for colon cancer than for rectal
cancer (p(heterogeneity)<0.001) and for those who were physically active versus inactive (p(interaction)
= 0.05). Models including other previously identified promoter polymorphisms did not provide a better
prediction of colorectal cancer risk. CONCLUSIONS: Our results support the hypotheses that IGF1
plays a role in colonic carcinogenesis and that genetically inherited variation in IGF1 expression
influences risk of colorectal cancer.
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Abstract 
Rationale 
Insulin-like Growth Factor (IGF)-1 has been proposed to mediate the obesity-related 
carcinogenic effects of “western lifestyle”.  While genetic factors explain at least half of inter-
individual IGF1 variation, the IGF1 polymorphisms hypothesized to underlie the variation in 
cancer incidence rates remain ill-defined.   
Methods 
We used a comparative genomics approach to identify putative regulatory polymorphisms in 
the IGF1 promoter region within a rapidly westernizing population, the Singapore Chinese.  
Association of IGF1 genotype with colorectal cancer risk was assessed among 298 colorectal 
cancer cases and 1142 controls nested within the Singapore Chinese Health Study.   
Results 
We identified a common (minor allele frequency = 0.36) single nucleotide polymorphism 
(SNP), IGF1-2995 C/A, within a consensus domain for an octamer binding factor (Oct1/Oct2) 
transcription factor binding site.  Possession of one or two copies of the minor allele 
(genotypes AA and CA) conferred an approximate 40 per cent decrease in risk in comparison 
to genotype CC (odds ratio: 0.59; 95 percent confidence interval: 0.45, 0.77).  This 
association was stronger for colon than for rectal cancer (
Ρheterogeneity< 0.001) and for those 
who were physically active vs. inactive (Ρinteraction=0.05).  Models including other previously 
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identified promoter polymorphisms did not provide a better prediction of colorectal cancer 
risk.   
Conclusions 
Our results support the hypotheses that IGF1 plays a role in colonic carcinogenesis and that 
genetically inherited variation in IGF1 expression influences risk of colorectal cancer. 
 
 
Background 
Although “Western lifestyle” is thought to predispose to colorectal cancer1, the 
mechanistic basis remains unclear.  Rapidly westernizing populations, i.e., Japan, Hong 
Kong and the Southeast Asian island nation of Singapore has been faced with the doubling 
of colorectal cancer rates in the past two decades.  Insulin-like Growth Factor (IGF)-1 is 
thought to mediate the insulin resistance-related carcinogenic effects of “western lifestyle”2-4.  
Adoption of a western diet is associated with significant increases in serum IGF1 levels5.  
Extensive evidence, both in vitro and in vivo, suggests that IGF1 promotes colorectal cancer 
growth6-15, prevents apoptosis16-18, and increases metastasis19.  IGF1 effects its multiple 
roles at the endocrine, paracrine and autocrine levels20.   
Significant heterogeneity in IGF1 levels, both circulating (endocrine) and local 
(paracrine and autocrine), exists among normal healthy individuals, both within and between 
ethnic groups21-25.  This population variation in IGF1 levels is hypothesized to underlie the 
variation in cancer incidence rates. To examine this hypothesis, six prospective population-
based studies have examined circulating IGF1 (serum or plasma levels measured at one 
time point during middle-age) as a proxy for IGF1 mitogenic actions in the colorectum26-31.  
Individuals with higher levels of circulating IGF1 (uppermost quartile or quintile) were found to 
be at increased risk of developing cancers of the colorectum (meta-analyses of the first five 
studies32).  
IGF1 variability is, in part, genetically determined, with genetic factors contributing an 
estimated 50% of the variability in circulating IGF1 levels33,34.  The genetic basis that 
underlies IGF1 variability, however, remains poorly defined.  Considerable allelic imbalance 
in IGF1 gene expression argues for the contribution of cis-acting regulatory polymorphisms25.  
Although IGF1 tag SNPs have been associated with circulating IGF1 levels35, the functional 
polymorphisms that might be mediating these associations have not been identified.  A 
cytosine-adenosine dinucleotide repeat sequence (CA15-22) that resides in the promoter 
region has been inconsistently associated with serum levels and with colorectal cancer risk.  
However, we have previously argued that this microsatellite is not responsible for variation in 
IGF1 levels, but rather is in linkage disequilibrium with other, functional genetic variants36.   
The CA15-22 polymorphism is localized to a haplotype block that spans 20 kilobase 
pairs upstream from the IGF1 translation start site.  We have previously observed a signal in 
this haplotype block in a case-control study nested within a prospective cohort of Han 
Chinese in Singapore36, with recent findings of a history of physician-diagnosed diabetes 
mellitus as a risk factor for colorectal cancer37.  Hence, we propose that this haplotype block 
spanning the IGF1 promoter harbors functional IGF1 polymorphisms that may impact cancer 
risk in the population.  To localize candidate regulatory sequences within this haplotype 
block, in the current study we employed a comparative genomics strategy.  The assumption 
is that nucleotide sequences involved in regulating gene expression maintain a higher 
similarity than do non-critical sequences under the neutral evolution model.  Within this 20 
KBp haplotype block, we identified four regions that are evolutionarily conserved across 
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vertebrate species (human, mouse, rat, dog).  These four regions lie within ten kilo base 
pairs from the transcription start site (Figure 1).  No conserved regions were identified in the 
upstream ten kilo base pairs; the majority of the upstream genomic region harbored repetitive 
elements specific to humans, e.g. Alu sequences.  We then resequenced these evolutionarily 
conserved regions (ECRs) in a sub-sample of our study population (60 Han Chinese, 
Singapore Chinese Health Study controls).  We identified one IGF1 promoter SNP that lies in 
a potentially functional element.  To interrogate the role of insulin resistance and colorectal 
cancer in a relatively lean population, we examined this newly identified SNP, along with 
another ECR SNP that we previously studied, for association with colorectal cancer risk36.   
 
Materials and Methods 
Study Population  
The study design and subject recruitment of the Singapore Chinese Health Study 
have been described38. Briefly, 63,257 Chinese women and men aged 45 to 74 years and 
belonging to the Hokkien or Cantonese dialect group were enrolled in the study between 
April 1993 and December 1998. At recruitment, information on lifestyle factors and usual diet 
over the last year was obtained through in-person interviews. The Institutional Review 
Boards at the National University of Singapore, the University of Minnesota and the 
University of Southern California approved this study. 
Incident cancer cases among cohort members were identified through record linkage 
with the nationwide Singapore Cancer Registry database 39. As of April 30, 2002, 592 
colorectal cancer cases had occurred among cohort participants. All cases were 
histologically confirmed except 3 who were ascertained by death records and clinical 
evidence. Between April 1994 and July 1999, we attempted to collect blood (or buccal cells if 
subjects refused blood donation) and single-void urine specimens from a random 3% sample 
of cohort enrollees.  Details of this biospecimen collection were previously described (41).  
Blood or buccal cell samples were collected from 1194 subjects (63% of total eligible 
subjects).  After excluding 5 subjects with prevalent history of colorectal cancer and 13 
subjects who developed colorectal cancer by April 30, 2002, the remaining 1176 subjects 
constituted the comparison group for this case-control analysis. In addition, we also 
attempted to collect blood/buccal cells and urine samples from all incident colorectal cancer 
cases.  Of the 592 colorectal cancer cases, 312 (52%) donated blood/buccal cell samples for 
genetic analyses. Two cases were later excluded due to misclassification of cancer type. 
These 310 cases with available DNA samples constituted the case group of our study.  Of 
the 310 available biospecimens, 50 were collected pre-diagnostically.  Of the 260 cases that 
were collected post-diagnostically, median time from diagnosis to blood draw was 9.5 
months. Compared with colorectal cancer cases who did not donate blood or buccal 
samples, those who donated had a similar mean of age at cancer diagnosis (65 versus 66 
years). They were also more likely to be male (57% versus 49%), of the Cantonese dialect 
group (45% versus 37%) and more educated (69% versus 60% had formal education). There 
was no difference between these two groups by level of body mass index, cigarette smoking, 
alcohol drinking or history of diabetes mellitus.  
Sample size 
 Of the 310 cases and 1176 controls with biospecimens available for this study, 
genotype was missing for 12 cases and 34 controls, leaving a final sample size of 298 cases 
and 1142 controls.   
In Silico Methods 
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 To identify ECRs in the region upstream of the first IGF1 translation start site 
(nucleotide 84199 in NCBI accession # AC010202), we compared the human sequence 
(NCBI Build 35 in the UCSC human May 2004 assembly, hg17) with mouse, rat and dog 
(UCSC assembly: mm6, rn3, canFam1 respectively) sequence.  Pairwise alignments were 
constructed and the nucleotide level match-mismatch similarity profiles were compared with 
the blastz algorithm40 incorporated in the ECR Browser portal41.  Regions with conserved 
elements were defined as intervals that exceed the threshold of 200 base pairs with >80% 
nucleotide identity.  Using the MatInspector software (http://www.genomatrix.de/), putative 
transcription factor binding sites within the ECRs were predicted, and the potential impact on 
transcription factor binding was calculated for any SNPs discovered in the re-sequencing 
process 
Laboratory Methods 
Resequencing  
 With the exception of ECR1, which we previously resequenced 36, the ECRs were 
resequenced in sixty individuals from the Singapore Chinese Health Study.  Primers (forward 
and reverse) were 5’TGATGTGTCAGTCCCCTG3’ and 5’GGAGTCTGTGTGCCAGAGTG3’ 
for ECR2; 5’TGGTGGCATGTTTATTGCTC3’ and 5’GCTCGGTGCACAGATATAACC3’ for 
ECR3; and 5’AAGACTGGGAACATGGCTTG3’ and 5’AGCCCAAGAGGAGTTCAGGT3’ for 
ECR4.  Sequencing was carried out on an ABI Prism 3700 DNA Sequencer (PE Biosystems, 
Foster City CA).   
Genotyping  
 Genomic DNA was isolated from peripheral blood lymphocytes and buccal cell 
samples using a QIAamp 96 DNA Blood Kit (Qiagen, Valencia, CA).  The TaqMan 
genotyping assay for the IGF1-533 SNP (rs5742612, dbSNP build 124) was previously 
described36. The genotypes for the IGF1 -2995 C/A SNP (rs12579108, dbSNP build 124) 
were determined using the fluorogenic 5’-nuclease assay 42. The oligonucleotide primers for 
amplification of the region surrounding the SNP were 5’AGG AGT GGA TGT TCT TAT GAT 
AAG CA3’ and 5’ CTG CAA AAA TCT GAC AGT GAG ATA TG3’.  The fluorogenic allele-
specific oligonucleotide probes (TaqMan MGB Probes, Applied Biosystems Inc, Foster City, 
CA) to detect each of the alleles were: a) G allele: VIC labeled 5’ TCC TTG CGG TTA GCT A 
3’; b) 6FAM-labelled 5’ATC CTT GCT GTT AGC TAT 3’.  PCR amplification using ~ 10ng of 
genomic DNA was performed in a thermal cycler (MWG Biotech, High Point, NC) with an 
initial step of 95°C for 10 mins followed by 95°C for 25sec and 50 cycles of 62°C for 60 sec.  
The fluorescence profile of each well was measured in an ABI 7900HT Detection System and 
the results analyzed with Sequence Detection Software (ABI).  All analyses were performed 
blinded to case or control status.  Twenty-four samples were analyzed in duplicate, with a 
concordance rate of 100%.  
Statistical Methods 
To assess strength of association between genotypes and cancer risk, unconditional 
multiple logistic regression models43 were fit and odds ratio (ORs) and their corresponding 
95% confidence intervals (CIs) were reported. All logistic regression models included age at 
recruitment (continuous), year of recruitment, gender and dialect group (Cantonese, 
Hokkien) as covariates.  Colorectal cancer risk factors considered as potential confounders 
were body mass index, height, education levels, alcohol intake, smoking history, physical 
activity, calcium intake, and dietary fat intake.  None were included in the final model 
because inclusion did not substantially alter (>5%) the parameter estimates for the 
exposures (genotypes).  
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Colorectal cancer was coded by anatomic subsite per the International Classification 
of Disease Oncology (2nd ed.) as colon (C18.0-C18.9) or rectal (C19.0-C20.0) cancer. To 
test for heterogeneity of odds ratios across anatomic subsite, polychotomous logistic 
regression models were fit and likelihood ratio tests were conducted.   
To investigate possible effect modification by sex, measures of energy balance (body 
mass index and physical inactivity), and factors associated with serum IGF1 in this 
population (calcium intake, saturated fats, physical inactivity and vitamin intake)44, the 
respective multiplicative interaction terms were included in the regression models and 
likelihood ratio tests were conducted.  
Allele frequencies were determined by gene counting45. Departures from Hardy-
Weinberg equilibrium (HWE) were assessed by testing the difference between the observed 
(sampled) and expected (under HWE) genotype frequencies in controls using a χ2 test46.  
Linkage disequilibrium (LD) between IGF1 polymorphisms was assessed by Lewontin’s D' 
and R247.  
Individuals were assigned a diplotype (pair of haplotypes) based on their combination 
of genotypes at the -2995 and -533 loci.  Since two haplotypes, accounted for nearly 100% of 
haplotype diversity, phase was known with near certainty and double heterozygotes were 
assigned as heterozygotes for the two common haplotypes.  Diplotypes were categorized 
into four groups:  homozygotes for the common at-risk haplotype, heterozygotes for the two 
common haplotypes, homozygotes for the common protective haplotype, and all others (rare 
combinations).  Odds ratios were estimated to compare each group to the baseline group 
(homozygotes for the protective haplotype).  
 We selected among competing statistical models using the smallest values for the 
Akaike Information Criteria (AIC)48,49 as an indicator or global fit.  AIC was calculated to 
compare model fit among these 4 models: a) baseline covariate model (no genetic effects); 
b) baseline model plus the -2995 locus only; c) baseline model plus the -533 locus only and, 
d) baseline model plus diplotype.   
 Serum IGF1 and IGFBP3 measurements 
 Of the 1176 controls in this study, 628 had serum IGF1 and 595 had serum IGFBP3 
measurements available from a previous sero-epidemiologic study in which 628 controls 
were randomly sampled from the entire cohort of nearly 60, 000 subjects (described 
previously by Probst-Hensch and colleagues44).  Of these 628, 12 had no genotype data 
available.  Analysis of covariance was used to compare distributions of natural log-
transformed IGF1 and IGFBP3-adjusted IGF1 by genotype categories.  Age, sex, body mass 
index, dialect group and year of recruitment were also considered as potential confounders 
but were not reported as inclusion did not substantially alter (>5%) the parameter estimates.   
 All P-values are two-sided and statistical analyses were performed using STATA 10.0 
(Stata Corp, College Station, TX). 
Results 
Study characteristics 
 The baseline characteristics of the Singapore Chinese Health Study cohort have 
been previously described36. For the case-control study nested within the cohort, Table 1 
describes the distributions of demographic and risk factors by case/control status.  Cases 
were more often male, were heavier, slightly but significantly taller (2 cm), less educated, 
and more likely to be smokers. 
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Table 1.   Selected characteristics of colorectal cancer cases and controls  
nested within the Singapore Chinese Health Study 
Characteristics Controls (n=1142)a Cases (n=298)a  P-valueb 
Sex 
 Males 489 (42.8) 169 (56.7)  
 Females 653 (57.2) 129 (43.3)   <0.001 
Dialect Group 
 Cantonese 561 (49.1) 133 (44.6) 
 Hokkien 581 (51.9) 165 (55.4)  0.17 
Body Mass Index (kg/m2) 
 ≤ 20 180 (15.8) 46 (15.4)  
 20-<24 638 (55.9) 141 (47.3)  
 24-<28 261 (22.8) 90 (30.2)  
 28+ 63 (5.5) 21 (7.1)    0.03 
Height c  
      159.3 (7.5)  160.9 (8.0)    0.02 
Physical inactivity d  
 Yes 942 (82.5) 247 (82.9) 
 No 200 (17.5) 51 (17.1)   0.87 
Education level 
 None (formal) 305 (26.7)    93 (31.5)   
 High school   770 (67.5)  195 (65.2)  
      Post-high school   44 (3.8)  6 (2.0)  
 University 23 (2.0)  4 (1.4)   0.003 
Cigarette smoking (cigarette and/or water pipe) 
 Never 829 (72.6) 178 (59.7)   
 Former 127 (11.1) 49 (16.5) 
 Current 186 (16.3) 72 (23.8)  <0.001 
Frequency of alcohol consumption 
 Nondrinkers 935 (81.9) 236 (79.2)    
 Monthly 85 (7.4) 19 (6.4) 
 Weekly 89 (7.8) 26 (8.7) 
 Daily 33 (2.9) 17 (5.7)  0.20 
Total calories (kcal/day)         
 1484.6 (831.4, 2483.5)  1491.0 (808.3, 2592.5)  0.72 
Total calcium intake (mg/day)  
  373.5 (158.7, 858.1)  360.7 (153.7, 793.3)   0.53 
Total fiber intake (g/day) 
  12.3 (5.1, 23.2) 11.9 (4.2, 22.9)  0.66 
Total fat (g/day)  
  40.6 (19.8, 82.2)  39.8 (18.3, 77.5)   0.58  
 
a Number of subjects (%), median (5th percentile, 95th percentile) for skewed distribution (dietary factors) or 
mean(standard deviation) for normal distribution (height). b Two-sided P-values derived from Kruskal-Wallis test. 
cPhysical inactivity: Yes=No weekly vigorous or strenuous sports and ≥9 h of sitting/day; No=All others. 
 
Identification of ECRs and Polymorphisms  
 We identified four ECRs in the region upstream of the IGF1 translational start site 
(Figure 1).  Locations are:  nt:1587-2053 in NCBI#S85346 for ECR1; nt 82871-83140, 81301-
81600, and 80831-81100 in NCBI#AC010202 for ECR2, ECR3, and ECR4.   
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We previously identified 2 SNPs (IGF1 -533C/T and -484G/A) in ECR1 in complete LD 
(linkage disequilibrium) with each other36.  In this study, we identified one additional common 
SNP (minor allele frequency, MAF=0.35), IGF1-2995 G/A (rs12579108, dbSNP build 127), 
which has been reported in the Perlegen polymorphism database to be common in Han 
Chinese (MAF=0.42) and Japanese but rare in European-Americans and African-Americans.   
Association between IGF1 genotype and colorectal cancer 
Table 2 presents genotype distributions for the -2995 C/A SNP in Singapore Chinese 
cases and controls.  Genotype distributions did not deviate from Hardy-Weinberg 
expectations among cohort controls.  Possession of one or two copies of the A allele 
(genotypes AA and CA) conferred an approximate 40 per cent decrease in risk in comparison 
to genotype CC.  This association was stronger for colon than for rectal cancer 
(heterogeneity p< 0.001).  
 
Table 2. Odds ratios (ORs) and 95 percent confidence intervals (95%CIs) 
for the IGF1 -2995 C/A genotype and colorectal cancer 
 Genotype Controls(%)  Cases(%)                OR(95%CI) a 
 CC  482(42.2)  160(53.7)  1.00 (referent) 
 CA  532(46.6)  106(35.6)  0.56 (0.42,0.75) 
 AA  128(11.2)    32(11.7)  0.68 (0.43,1.07) CA + AA 
vs. CC      0.59 (0.45,0.77) 
         
Subsite 
Colon b     
CC  482(42.2)    98(56.3)  1.00 (referent) 
 CA  532(46.6)    59(33.9)  0.51 (0.36,0.73) 
 AA  128(11.2)    17(9.8)  0.59 (0.33,1.04) CA + AA 
vs. CC      0.53 (0.38,0.74) 
 
Rectal b  
CC  482(42.2)    62(50.0)  1.00 (referent) 
 CA  532(46.6)    47(37.9)  0.65 (0.43,0.98) 
 AA  128(11.2)    15(12.1)  0.83 (0.45,1.53) CA + AA 
vs. CC      0.68 (0.47,1.00) 
       P for heterogeneity < 0.001 
 
a
 odds ratio from unconditional logistic regression; adjusted for age at recruitment, gender, dialect groups 
(Cantonese, Hokkien), and year of recruitment. 
b
 odds ratios from polychotomous logistic regression; adjusted for age at recruitment, gender, dialect groups 
(Cantonese or Hokkien), and  year of recruitment. 
 
Effect modification by energy balance 
We examined two measures of energy balance as potential modifiers of the IGF1 
genotype-cancer risk association: 1) physical inactivity (no weekly vigorous or strenuous 
sports and ≥9 h of sitting/day), and 2) body mass index.  The effect of IGF1 -2995 C/A 
genotype was approximately two-fold stronger in individuals who were physically active 
(Table 3; Pinteraction=0.05).  No effect modification was detected by body mass index.  In 
addition, no effect modification was observed for the dietary factors that were previously 
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reported  to predict serum IGF1 levels in this population44: calcium intake, saturated fats or 
vitamin intake (data not shown).   
 
Table 3. Odds ratios (ORs) and 95 percent confidence intervals (95%CIs) 
for the IGF1 -2995C/A genotype and colorectal cancer by physical activity 
 Genotype Controls(%)  Cases(%)                OR(95%CI) a 
 
Physically inactive 
(No weekly vigorous or strenous sports and 9 h of sitting/day) 
 CC  400(42.5)  127(51.4)  1.00 (referent) 
 CA + AA 542(57.5)  120(48.6)  0.66 (0.49, 0.89) 
        
Physically Active   
CC    82(41.0)    33(64.7)  1.00 (referent) 
 CA + AA 118(59.0)    18(35.3)  0.30 (0.15, 0.60) 
 
       P for interaction = 0.05b 
 
a
 odds ratio from unconditional logistic regression; adjusted for age at recruitment, gender, dialect groups 
(Cantonese, Hokkien), and  year of recruitment. 
 
Unphased multilocus genotype analysis (IGF1-533C/T and IGF1-2995C/A) 
We previously reported an association between colorectal cancer risk and a SNP 
downstream from the -2995 locus, IGF1 -533C/T36.  The two SNPs are in tight linkage 
disequilibrium (D'=0.97 and R2=0.90).  Thus, in this population, only two common -2995/-533 
haplotypes exist, C_T and A_C, having estimated frequencies of 0.66 and 0.33, respectively.  
Odds ratios for the single locus and diplotype models were similar (Table 4). The best fitting 
model, as indicated by the lowest AIC (Table 5), was the model containing baseline 
covariates plus the -2995 genotype.  
 
Table 4 Diplotypes of IGF1 loci  -2995C/A and -533C/T and colorectal cancer risk.  
Genotype 
combinations at 
loci -2995 C/A and 
-533 C/T 
 
Diplotypes Controls / 
Cases 
(1031 / 
295)a 
# risk (CT) 
haplotypes 
Odds Ratio 
(95%CI)b 
-2995CC, -533TT C_T/C_T 435/154 2 1.00  
 
-2995CA, -533CT C_T/A_C 
 
448/98 1 0.61 
(0.45,0.83) 
-2995AA, -533CC A_C/A_C 106/30 0 0.72 (0.45,1.15) 
C_T/A_C +  
                                  A_C/A_C   554/128 
0-1 0.63 
(0.48,0.83 ) 
All others All others 42/13 unphased 0.73 
(0.37, 1.44) 
    P =0.01 c 
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a 111 controls and 3 cases had missing genotypes for IGF1 -533 
b
 Odds ratio estimated from logistic regression, adjusted for age at recruitment, gender, dialect groups 
(Cantonese, Hokkien), and  year of recruitment. 
c
 trend-test assesing the linear trend of the A_C haplotype dosage, i.e. 0 vs. 1 vs. 2 copies of the A_C haplotype 
 
Table 5 Comparison of the model fit among the single marker and diplotype models (N=294 
cases & 1035 controls having complete genotype data) 
Model Odds Ratio (95%Confidence 
Interval) 
Akaike’s 
Information 
Score 
Baseline model: 
Baseline covariatesa 
Reduced Model 0.970 
Baseline model plus  
 -533 T/Cb  
TC + CC vs. TT: 
0.66 (0.50,0.86) 
0.966 
Baseline model plus 
 -2995 C/Ac  
CA + AA vs. CC: 
0.61 (0.47,0.81) 
0.963 
Baseline model plus  
diplotypesd  
C_T/A_C + A_C/A_C 
vs. C_T/C_T  
0.63 (0.48, 0.83) 
0.966 
a age at recruitment, gender, dialect groups (Cantonese, Hokkien), and  year of recruitment. 
bTC+CC vs TT: individuals with at least one copy of the risk allele -533C (genotypes TC or CC as a referent 
group) in comparison to individuals with genotype TT.  
cCA + AA vs. CC: individuals with at least one copy of the risk allele -2995A (genotypes CA and AA) versus 
individuals with genotype CC.  
dC_T/A_C + A_C/A_C vs. C_T/C_T:  individuals with at least one copy of the risk haplotype  -533A_-2995C ( 
haplotype pairs of -533C_-2995T/-533A_-2995C or haplotypes pairs of -533A_-2995C/-533A_-2995C) as a 
referent group in comparison to individuals with diplotype -533C_-2995T. 
 
IGF1 genotype-phenotype (serum IGF1) association 
 IGF1 genotype did not predict serum IGF1 levels among controls (p=0.15).  The 
geometric mean values for the -2995 CC, CA and AA genotypes were 122.6, 131.1, and 
129.7 ng/mL respectively.  Adjustment for IGFBP3 did not alter the results. 
Discussion 
 This is the first report of the characterization of the allelic architecture surrounding the 
IGF1 promoter region in relation to cancer risk.  A putative regulatory IGF1 SNP in the 
promoter region is associated with reduced colorectal cancer risk of approximately 40 per 
cent.  The effect is stronger in colon cancer versus rectum cancer and is more apparent in 
persons who are physically active.   
The human IGF1 gene spans approximately 90 kb and encodes five exons, two 
alternative first exons (exon 1 and exon 2) and 4 coding exons.  Two common IGF1 splice 
mRNA variants arise from two IGF1 promoters.  No common sequence variation (frequency 
> 0.02) was observed in the coding regions of the IGF1 gene.  Thus, cis-acting genetic 
variants that affect IGF1 levels are probably in the regulatory regions, i.e., upstream 
enhancers, promoter, introns or 3’ untranslated regions.    
Little is known about regulatory IGF1 polymorphisms and their impact on cancer risk.  
The only promoter region variant that has been studied is a cytosine-adenosine dinucleotide 
(IGF1(CA)n) repeated 15-22 times, approximately one kilobase upstream of the first 
transcription start site of the more common splice variant.  This IGF1(CA)n microsatellite is 
associated with colorectal cancer in the Singapore Chinese (this population) as well as in 
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some 50,51 but not all Caucasian populations52.  In those studies reporting an association, 
different alleles were associated with risk.  The hypermutable nature of the microsatellite may 
result in an allele being linked to various haplotypic backgrounds. Thus we considered the 
possibility that these inconsistent associations are due to linkage disequilibrium with another 
functional polymorphic variant.   
To dissect the haplotype block for these functional SNPs, we identified and 
resequenced regions with a high probability to harbor functional elements.  The two SNPs 
identified in our previous report36 are in a conserved region that covers the 5’ untranslated 
region (ECR1, Figure 1).  The functionality of these SNPs is unknown.  Upon resequencing 
the remaining conserved DNA stretches (ECR2-4, Figure 1), we identified one additional 
SNP, IGF1-2995 C/A.  Based on transcription factor binding site prediction algorithms, this 
IGF1-2995 C/A resides in a consensus domain for a transcription factor: octamer binding 
factor (Oct1/Oct2).  The A allele (protective allele) destroys the predicted binding site for 
Oct1/Oct2. Thus, in silico prediction suggests that the -2995C (risk) allele is more likely than 
the -2995A (protective) allele to bind octamer binding factor proteins.  Oct2 proteins are 
found mainly in cells of the lymphoid system, and are reported to be overexpressed in colon 
tumors (curated database repository of gene expression profiles, NCBI Gene Expression 
Omnibus53).   
IGF1 is thought to mediate the effect of energy balance on cancer. We previously 
reported that high physical activity was associated with decreased serum IGF1 in this 
population30.  The IGF1-2995 C/A effect on colorectal cancer is more apparent in physically 
active as compared to physically inactive persons.  In agreement with our observations, 
among highly active individuals in a large (1,346 colon cancer cases and 1,544 controls) 
predominantly Caucasian study, a 40% reduction in colon cancer risk was observed with the 
IGF1(CA)n 192/192 genotype (interaction p=0.01) (51), which is in partial LD with SNPs in 
the IGF1 promoter.  Neither study detected effect-modification by BMI, another measure of 
energy balance that may not be a sensitive indicator of insulin sensitivity54.   
The IGF1 promoter genotype-colon cancer association observed in our study might be 
expected to act through plasma/serum level changes.  Further, if the circulating IGF1 levels 
are considered as an intermediate phenotype, the proportion of variance due to the IGF1 
SNP is expected to be larger for serum IGF1 levels as compared to cancer incidence rates.  
However, in our study, the -2995 C/A SNP did not predict serum IGF1 levels in 628 controls.  
Serum IGF1 concentration parallels hepatic IGF1 expression but does not correlate with non-
hepatic expression55.  Serum levels may not be a good marker of local tissue exposure.  
Rather, IGF1 genotypes may be a better marker for colorectal cancer risk.   
 Using association methods, we could not definitively distinguish between several 
causal models (Table 5).  Differences between the models, as assessed by information 
criteria, are small.  The best fitting model contains a single SNP at position -2995, which is 
located in an evolutionarily conserved sequence and is predicted to alter the binding site of a 
transcription factor that appears to be upregulated in colorectal cancer.  Further functional 
studies of this polymorphism are warranted.   
In any case-control study, the potential for population stratification exists.  The 
Singapore Chinese Health Study is a population-based cohort comprised of subjects drawn 
from an ethnically homogeneous southern Chinese population (Han Chinese).  Specifically, 
this population originates from the contiguous coastal provinces, Fujian and Guangdong, and 
was shown to cluster tightly into a genetically homogeneous subcluster within the relatively 
genetically similar Southern Chinese population56,57.  Therefore, we believe that population 
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stratification is unlikely to explain our observed IGF1-colorectal cancer genetic association58.  
One limitation of our study is that it is based on a case-control that was sampled from an 
ongoing cohort with differential clinical stage between cases who provided biospecimens 
(46.8% with stage 3 and 4 cancer) and those who did not give biospecimens (62.0%).  
However, we do not have any strong evidence that cancer stage or mortality differs by IGF1 
genotypes.  Another limitation is the relatively modest sample size.  However, the ongoing 
cohort will continue to accrue cases and we will eventually be able to confirm or refute our 
finding.  In the mean time, we believe that the finding of a new, potentially functional SNP in 
Asian populations warrants independent replication in other Han Chinese population.     
Several factors may explain why our study is the only one to date to report an 
association between risk of colorectal cancer and an IGF1 SNP.  The SNPs examined in this 
study were chosen for high prior probability of functionality.  They also happen to be rare in 
Caucasians but common in Chinese.  Furthermore, IGF1 has been reported to be 
differentially expressed by ethnicity, with a 2.2-fold higher expression in Asians than in 
Caucasians59.  Thus the association between IGF1 genetic variation and colorectal cancer 
risk may have been more readily detectable in this cohort of Han Chinese than in some other 
studies.  However, the implication of this study, that variation in IGF1 expression is related to 
risk of colorectal cancer, may be more broadly generalizable.  What remains to be 
determined are the genetic and non-genetic determinants of IGF expression that are most 
relevant in other populations.  
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Figure 1.  Conservation profiles of the human IGF1 upstream regulatory region in reference to the mouse (top 
panel), rat (middle panel) and dog (bottom panel). The vertical axis for each panel indicates the percent 
identity.  The human IGF1 DNA sequence lies along the horizontal axis. Colored peaks depict regions of 
conservation with blue indicating exon 1, yellow indicating the 5’UTR and red indicating the 
upstream regulatory region. Green bars in the last panel indicate regions of repeat sequences.   Evolutionarily 
conserved regions (exceed at 200 bp/80% identity threshold) are indicated by red bars. Black boxes delimit the 
regions that were resequenced for polymorphisms in 60 Han Chinese. 
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